CCK, cholecystokinin, 885

N. diseases: 326; N. variants: 7
Disease: Gastrointestinal symptom ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0426576
Disease: Gastrointestinal symptom
Gastrointestinal symptom 		0.020 Biomarker phenotype BEFREE Intraduodenal quinine did not affect antral, pyloric or duodenal pressures, plasma CCK (pmol/L [peak]; control: 3.6 ± 0.4, Q37.5: 3.6 ± 0.4, Q75: 3.7 ± 0.3, Q225: 3.9 ± 0.4), appetite perceptions, gastrointestinal symptoms or energy intake (kcal; control: 1088 ± 90, Q37.5: 1057 ± 69, Q75: 1029 ±7 0, Q225: 1077 ± 88). 31177650 2019
CUI: C0426576
Disease: Gastrointestinal symptom
Gastrointestinal symptom 		0.020 Biomarker phenotype BEFREE Antropyloroduodenal pressures were measured continuously, and plasma cholecystokinin (CCK), ghrelin, and glucagon-like peptide-1 (GLP-1) concentrations, appetite perceptions, and gastrointestinal symptoms at 15-min intervals. 31051504 2019